XML 46 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Warrant Liability (Tables)
12 Months Ended
Dec. 31, 2022
Warrant Liability  
Schedule of Warrant Liability

The warrants outstanding and fair values at each of the respective valuation dates are summarized below:

 

Warrant Liability  Warrants
Outstanding
   Fair Value
per Share
   Fair Value 
Fair value as of year ended 12/31/2020   201,572        $123 
Fair value at initial measurement dates   63,733   $3.2097   $203 
Change in fair value of warrant liability             (8)
Fair value as of year ended 12/31/2021   265,305        $318 
Modification of warrants   -        $57 
Change in fair value of warrant liability   -         (133)
Fair value as of year ended 12/31/2022   265,305        $242 

 

The warrant liabilities are considered Level 3 liabilities on the fair value hierarchy as the determination of fair value includes various assumptions about future activities and the Company’s stock prices and historical volatility of other comparable public companies used as inputs. As of December 31, 2022, none of the warrants have been exercised.

 

The fair value of the warrant liabilities was measured using a Black-Scholes model. Significant inputs into the model at the inception are as follows:

 

                              Future 
                              Estimated 
                              Quarterly 
       Warrant      Interest       Time to   Calculated   Dividend 
Black -Scholes  Exercise   Expiration  Stock   Rate   Volatility   Maturity   fair value   per 
Assumptions  Price   Date  Price (8)   (annual)(9)   (annual) (10)   (Years)   per share   share(11) 

September 2,

2021(1)

  $.0525  

September 2,

2026

  $3.50    0.78%   182.74%   5.0   $0.3325   $ 

March 11,

2021(2)

  $4.3755.25  

March 11,

2026

  $3.50    0.17%   172.54%   5.0   $0.3325- 0.0329   $ 

February 3,

2021(3)

  $2.80  

February 3,

2024

  $2.80    0.18%   171.71%   3.0   $2.417461   $ 

December 24,

2020 (4)

  $2.80  

December 24,

2023

  $2.80    0.17%   172.54%   3.0   $2.422658   $ 

March 18,

2020 (5)

  $1.40  

March 18,

2023

  $1.40    0.66%   137.41%   3.0   $1.075547   $ 

September 10,

2019 (6)

  $0.49  

September 10,

2022

  $0.49    1.61%   139.84%   3.0   $0.38185   $ 

November 6,

2019 (7)

  $0.49  

November 6,

2022

  $0.49    1.60%   138.48%   3.0   $0.38255   $ 

 

Significant inputs into the model at the reporting period measurement dates are as follows:

 

                              Future 
                              Estimated 
                             Quarterly 
       Warrant      Interest       Time to   Calculated   Dividend 
Black-Scholes  Exercise   Expiration  Stock   Rate   Volatility   Maturity   fair value   per 
Assumptions  Price   Date  Price (8)   (annual) (9)   (annual) (10)   (Years)   per share   share (11) 

December 31,

2022(1)

  $.0525  

September 2,

2026

  $1.25    4.22%   287.87%   3.68   $0.0968371   $ 

December 31,

2022(2)

  $4.3755.25  

March 11,

2026

  $1.25    4.22%   288.66%   3.20   $0.096101 - 0.0957467   $ 

December 31,

2022(3)

  $2.80  

February 3,

2024

  $1.25    4.73%   352.74%   1.10   $0.0690620   $ 

December 31,

2022(4)

  $2.80  

December 24,

2023

  $1.25    4.73%   331.00%   0.98   $0.0681813   $ 

December 31,

2022(5)

  $1.40  

March 18,

2023

  $1.25    4.42%   147.61%   0.22   $0.0296661   $ 

December 31,

2022(6)

  $0.49  

September 10,

2022

  $1.25    4.42%   137.02%   0.35   $0.0091855   $ 

December 31,

2022(7)

  $0.49  

November 6,

2022

  $1.25    4.42%   149.27%   0.18   $0.0085006   $ 

 

                              Future 
                              Estimated 
                              Quarterly 
       Warrant       Interest       Time to   Calculated   Dividend 
Black-Scholes  Exercise   Expiration  Stock   Rate   Volatility   Maturity   fair value   per 
Assumptions  Price   Date  Price (8)   (annual) (9)   (annual) (10)   (Years)   per share   share(11) 

December 31,

2021(1)

  $.0525  

September 2,

2026

  $3.50    0.98%   205.16%   4.67   $0.0968371   $ 

December 31,

2021(2)

  $4.3755.25  

March 11,

2026

  $3.50    0.98%   205.16%   4.19   $0.096101 - 0.0957467   $ 

December 31,

2021(3)

  $2.80  

February 3,

2024

  $2.80    0.28%   205.16%   2.09   $0.0690620   $ 

December 31,

2021(4)

  $2.80  

December 24,

2023

  $2.80    0.28%   205.16%   1.98   $0.0681813   $ 

December 31,

2021(5)

  $1.40  

March 18,

2023

  $1.40    0.28%   205.16%   1.21   $0.0296661   $ 

December 31,

2021(6)

  $0.49  

September 10,

2022

  $0.49    0.09%   205.16%   0.69   $0.0091855   $ 

December 31,

2021(7)

  $0.49  

November 6,

2022

  $0.49    0.19%   205.16%   0.85   $0.0085006   $ 

 

(1) Based on the terms provided in the warrant agreement related to the issuance of common stock of on September 2nd, 2021

 

(2) Based on the terms provided in the warrant agreement related to the issuance of common stock of on March 11th, 2021
   
(3) Based on the terms provided in the warrant agreement related to the issuance of common stock of on February 3rd, 2021

 

(4) Based on the terms provided in the warrant agreement related to the issuance of common stock of on December 24th, 2020

 

(5) Based on the terms provided in the warrant agreement related to the issuance of common stock of on March 18th, 2020

 

 

(6) Based on the terms provided in the warrant agreement related to the issuance of common stock of on September 10th, 2019

 

(7) Based on the terms provided in the warrant agreement related to the issuance of common stock of on November 6th, 2019

 

(8) Based on the observable transaction value of common stock of per the most recent stock issuance financing agreements.

 

(9) Interest rate for U.S. Treasury Bonds, as of the issuance dates and each presented year ended date, as published by the U.S. Federal Reserve.

 

(10) Based on the historical daily volatility of guideline public companies in the healthcare industry and each presented year ended date.

 

(11) Current estimated dividend payments beyond initial four quarters. At a future date, the Company will review the working capital needs and make a final determination of any future dividend payments.